# FDA Inspection 1149614 - Octapharma Plasma Inc - July 29, 2021

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/954c601f-0ee3-438c-9488-8ef8ba196572
Source feed: FDA_Inspections

> FDA Inspection 1149614 for Octapharma Plasma Inc on July 29, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1149614
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2021-07-29
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1149614 - 2021-07-29](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/941f5500-2939-456e-8f30-c3b1fc76b6f0)
- [FDA Inspection 1050669 - 2018-05-04](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/a9e02f54-35cc-4f5c-bc3c-31b926113291)
- [FDA Inspection 956003 - 2016-01-19](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/2c3ae100-3938-4970-874c-98dec7a7f87a)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/d0081d27-b2af-40bb-b085-5b215f94e8a6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d